Table 4.
Univariate analysis of factors associated with overall objective and subjective improvement.
| IHS4 reduction ß (SD) |
p | PAIN reduction ß (SD) |
p | PRS reduction ß (SD) |
p | |
|---|---|---|---|---|---|---|
| Age | 0.02 (0.02) | 0.36 | 0.03 (0.02) | 0.2 | 0.03 (0.02) | 0.13 |
|
Sex Female–Male |
0.49 (0.33) | 0.14 | 0.23 (0.38) | 0.53 | 0.35 (0.32) | 0.26 |
| Hurley stage | 0.68 (0.46) | 0.15 | − 1.23 (0.52) | 0.02 | − 1.07 (0.44) | 0.01 |
| Baseline IHS4 | 0.42 (0.06) | < 0.0001 | − 0.02 (0.08) | 0.7 | − 0.06 (0.06) | 0.38 |
| Monot.- Comb | 0.14 0.31) | 0.65 | 0.04 (0.36) | 0.91 | − 0.13 (0.30) | 0.66 |
ß, Beta; Comb, infiltrations in combination with systemic treatment; IHS4, International Hidradenitis Suppurativa Severity Scoring System; Monot, infiltrations in monotherapy; PRS, patient reported severity; SD, standard deviation.